Navigating Patient Pain Under Stricter Opioid Prescribing Laws
Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.
Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.
Researchers examined the incidence, prevalence and trends for opioid prescriptions in patients with osteoarthritis.
Medicaid expansion is associated with a reduction in total opioid overdose deaths and with increases in methadone-related mortality.
In an effort to further address the current opioid crisis, the FDA contracted the NASEM to examine existing opioid prescribing guidelines and to help outline the type of research needed to fill the gaps in evidence.
Prescription opioid use among teens and young adults is higher than expected, with most obtaining the drugs from friends and family.
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
Opioids offer minor pain relief and functional benefits in patients with osteoarthritis (OA), with smaller benefits regarding pain for strong versus weak opioids.
Researchers compared the rate of opioid overdose-related hospitalizations among patients with systemic lupus erythematosus and rheumatoid arthritis vs the general population.
Researchers assessed opioid prescription patterns among patients with rheumatic diseases.
The drugs most frequently involved in drug overdose deaths in 2017 varied regionally in the United States.